How many times have you started to have a conversation with someone about Hepatitis C only to have it blow up in your face? Have you ever heard someone say something about Hep C that didn't seem quite right to you? You were probably right something was amiss. A discussion about Hepatitis C can...
As per Wikipedia, the definition of a stigma is as follows: "Stigma is a word that originally means a "sign", "point", or "branding mark"." Wikipedia goes on to call stigma "A badge of shame, a physical mark of infamy or disgrace." Damn that w...
Recently, the CDC (Center for Disease Control) issued a statement that all Baby Boomers should be tested for Hepatitis C. The question often comes up as to why this particular segment of people is so vulnerable. What does being born between 1945 and 1965 have to do with Hepatitis C? What was di...
Buyer Beware! There are several snake oil salesmen out there who are claiming to have cured their own Hepatitis C with herbs, supplements and parking lot gravel. Okay, maybe not the parking lot gravel but it might as well be. What you need to remember is that there are two different types of...
Most every adult woman (and an occasional man) has enjoyed a manicure and a pedicure at a nail salon or spa. That 30 minute pedicure can be so relaxing but are you aware of the danger lurking in that nail salon? Although few individuals recognize the medical risks associated with this common pr...
Downtown Tulsa - A local HIV and HCV prevention organization will hold its 11th annual benefit concert at the Mayo Hotel on August 24th.
Health Outreach Prevention Education, Inc. (HOPE), a 501(c)3 non-profit group offering STD outreach education and testing to Tulsa metropolitan area since 1998, holds the event each year to raise awareness and funds for prevention efforts.
The benefit concert, called DIVAS3 (Divalicious, Divafabulous, Divafantastic), will be held in the Crystal Ballroom at the Mayo Hotel beginning at 6:45 p.m. on August 24th.
The goal of DIVAS3 is to put an end to HIV (Human Immunodeficiency Virus) and HCV (Hepatitis C Virus) through education and testing. The idea is that if people are educated with the latest information on STDs and know their status, they can make informed decisions.
"Divas" scheduled to take the stage include Christy Hanewinkel, Cindy Cain, Heather Richetto-Rumley, John Sawyer, Kristin Nicole, Olivia Duhon, Pam Van Dyke, Rebecca Ungerman, Sarah Maud, and Tavis Minner.
Mia Fleming will host the evening's show, which will be produced by Spinning Plates Productions.
In addition to the dinner and entertainment, the event will also feature silent and live auctions.
Prizes will include a one-week stay in St. Kitts for six, one week in Belize for two, five nights at Big Sky Mountain Village for four, five nights at Rehoboth Beach for six, a plan-your-own dinner for twenty.
HOPE has already received early sponsorships from organizations and businesses such as the George Kaiser Family Foundation, the Oklahoma State Department of Health, WPX Energy, OMNI Lighting, Inc., Boomerang Printing, and many more.
Sponsorships start at $1500, individual tickets are $150, and the after party only tickets are $50.
As of December 31, 2008, there were approximately 4,605 people living with HIV in Oklahoma.
The Centers for Disease Control (CDC) recommends that everyone between the ages of 13 and 64 get tested for HIV at least once as part of routine health care.
Nationally and worldwide, one out of every 100 people is infected with HIV. One out of five people infected with HIV in the U.S. is unaware that they have it. One-half of new HIV diagnoses occur in people under the age of 25.
HOPE's Executive Director, Kathy Williams, told KTUL.com in March that three Oklahoma counties account for the majority of current HIV cases in the state—Oklahoma County (27.7%), Tulsa County (23.0%), and Cleveland (11.3%).
Tulsa County currently has an HIV positivity rate of 1%.
Tulsa County has an HCV positivity rate of 21%.
In addition to outreach education and testing, HOPE also operates the only statewide Oklahoma HIV/sexually transmitted infections (STI) resource hotline, 800-535-AIDS (2437).
For more information on HOPE or DIVAS3, visit www.hopetesting.org or call 918-749-TEST (8378).
Please sign the ATC Salvage Therapy Petition Join us in asking Congressman Alcee Hastings and Congresswomen Maxine Waters to send a ‘Dear Colleague’ letter to Anthony Fauci, Director of NIAID, asking for the federal facilitation of apricitabine (ATC). ATC is a phase III nucleoside reverse transcriptase inhibitor (NRTI) that has been shown to be safe and effective in treating people with HIV. It works against viruses that are resistant to several other nukes and could ...
Researchers from Johns Hopkins Children’s Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School announced today at CROI2013 the discovery of the first infant functionally cured of HIV. The baby, a female now two and a half years old, received 3 HIV medications when brought to the hospital at 30 hours old. Viral load tests were performed during the first few weeks that showed a rapidly decreasing viral load which reached ...
At the 19th International AIDS Conference (AIDS 2012) in Washington D.C., the CDC reported that only 1 out of 4 HIV patients in the U.S. have HIV under control, which is defined as complete viral suppression. Warning bells should be ringing in the scientific and HIV advocacy communities. While much progress has been made in the last three decades in the treatment of HIV, tens of thousands of people living with HIV (PLWH) are currently struggling to construct viable treat...
Paige Rawl is 17 and HIV positive, but while her life has been shaped by HIV it isn't ruled by it. When Paige Rawl starts her senior year at Indianapolis’s Herron High School next month, she'll be cheer captain and a member of the student government and prom committee. This summer, the 17-year-old held down a part-time job at Hollister, hawking the popular Southern California-inspired clothing brand. The all-American girl — who happens to be HIV positive. Paige was in...
The HIV community has been abuzz with the August FDA approval of what had been termed “the Quad”, the second one-pill-once-a-day combination antiretroviral drug. Marketed by Gilead under the name Stribild, the drug contains two NRTIs (tenofovir and emtricitabine), an integrase inhibitor (elvitegravir) and an integrase booster (cobicistat) and is approved for use in treatment naïve patients with either drug resistant or wild type virus. In comparison to Atripla, the first...

Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for SUSTIVA® (efavirenz), including dosing recommendations for...

California and other states would be pressured to amend or repeal criminal laws that single out HIV-positive people under a bipartisan bill co-authored and introduced this week by Rep. Barbara...
Mission Statement
At HIV Haven we wish to provide our readers with vital cutting edge information to help expand HIV knowledge and promote activism, particularly that which works towards an end to the HIV pandemic. It is our desire to bring to you the scientific, medical and social advances that given the appropriate attention and support, could change the course of the HIV pandemic, lessen the devastating effects of HIV and AIDS, better the quality and quantity of life for people living with HIV and even yield an eventual end to the HIV pandemic. We also provide the basics of HIV transmission and treatment.
We will focus on issues such as innovative drug development, strategic activist campaigns, HIV relationships and novel HIV and HIV cure research. We also will bring you advances in Hepatitis C (HCV), a common HIV co-infection. Whether you are living with HIV/AIDS, HIV and HCV, love someone who is, are an activist, advocate, researcher, physician or just an interested party, we hope here at HIV Haven we can help you find what you are looking for.